2 papers
stat.AP2023
Estimands in Real-World Evidence Studies
Jie Chen, Daniel Scharfstein, Hongwei Wang +6
A Real-World Evidence (RWE) Scientific Working Group (SWG) of the American Statistical Association Biopharmaceutical Section (ASA BIOP) has been reviewing statistical consideration…
stat.AP2019
Teasing out the overall survival benefit with adjustment for treatment switching to other therapies
Yuqing Xu, Meijing Wu, Weili He +2
In oncology clinical trials, characterizing the long-term overall survival (OS) benefit for an experimental drug or treatment regimen (experimental group) is often unobservable if…